Day One Biopharmaceuticals Files Amended 10-K, Details Executive Compensation and Ownership Amidst Servier Acquisition

summarizeSummary

Day One Biopharmaceuticals filed an amended 10-K, providing 2025 executive compensation, including a significant option repricing, and updated beneficial ownership details, all within the context of its pending acquisition by Servier.

check_boxKey Events

• Merger Confirmation

  The filing explicitly references the Agreement and Plan of Merger with Servier Pharmaceuticals LLC, dated March 6, 2026, for the company to become a wholly-owned subsidiary.

• Executive and Director Option Repricing

  In October 2025, stock options for named executive officers and directors were repriced, reducing exercise prices to $8.99 per share, re-incentivizing management prior to the acquisition. This is notable given the current stock price of $21.47.

• Updated Beneficial Ownership

  As of April 1, 2026, executive officers and directors collectively beneficially owned 7.6% of common stock, with AI Day 1 LLC (Access Industries) holding 13.2%.

• 2025 Compensation Details

  Detailed 2025 base salaries, annual cash bonuses (paid at 110% of target), and long-term equity incentive awards for named executive officers.

auto_awesomeAnalysis

This amended annual report (10-K/A) provides comprehensive details on executive and director compensation for 2025, as well as updated beneficial ownership information as of April 1, 2026. The filing explicitly confirms the ongoing merger agreement with Servier Pharmaceuticals LLC, announced on March 6, 2026, under which Day One Biopharmaceuticals will become a wholly-owned subsidiary. A notable event disclosed is the repricing of underwater stock options for named executive officers and directors in October 2025, reducing exercise prices to $8.99 per share. This re-incentivized key personnel prior to the acquisition announcement and is particularly significant given the company's current stock price trading near its 52-week high, largely driven by the acquisition news. This filing completes the annual reporting requirements by including information typically found in a proxy statement, offering investors a detailed look at the company's governance and compensation structure during a pivotal period leading up to its acquisition.